Choosing the best initial therapy for HIV-1 infection

被引：15

作者：

Clumeck, N ^{[1
]}

机构：

[1] Hop Univ St Pierre, B-1000 Brussels, Belgium

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 341卷 / 25期

关键词：

D O I：

10.1056/NEJM199912163412510

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1925 / 1926

页数：2

相关论文

共 11 条

[1] The care of HIV-infected adults in the United States [J].

Bozzette, SA ;

Berry, SH ;

Duan, NJ ;

Frankel, MR ;

Leibowitz, AA ;

Lefkowitz, D ;

Emmons, CA ;

Senterfitt, JW ;

Berk, ML ;

Morton, SC ;

Shapiro, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (26) :1897-1904

[2] Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [J].

Brinkman, K ;

Smeitink, JA ;

Romijn, JA ;

Reiss, P .

LANCET, 1999, 354 (9184) :1112-1115

[3] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].

Ledergerber, B ;

Egger, M ;

Opravil, M ;

Telenti, A ;

Hirschel, B ;

Battegay, M ;

Vernazza, P ;

Sudre, P ;

Flepp, M ;

Furrer, H ;

Francioli, P ;

Weber, R .

LANCET, 1999, 353 (9156) :863-868

[4] Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions [J].

Lucas, GM ;

Chaisson, RE ;

Moore, RD .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :81-+

[5] A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].

Montaner, JSG ;

Reiss, P ;

Cooper, D ;

Vella, S ;

Harris, M ;

Conway, B ;

Wainberg, MA ;

Smith, D ;

Robinson, P ;

Hall, D ;

Myers, M ;

Lange, JMA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937

[6]

MURPHY RL, 1999, 39 INT C ANT AG CHEM

[7] Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue [J].

Ruiz, L ;

van Lunzen, J ;

Arno, A ;

Stellbrink, HJ ;

Schneider, C ;

Rull, M ;

Castellà, E ;

Ojanguren, I ;

Richman, DD ;

Clotet, B ;

Tenner-Racz, K .

AIDS, 1999, 13 (01) :F1-F8

[8] Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1 [J].

Starr, SE ;

Fletcher, CV ;

Spector, SA ;

Yong, FH ;

Fenton, T ;

Brundage, RC ;

Manion, D ;

Ruiz, NM ;

Gersten, M ;

Becker, M ;

McNamara, J ;

Mofenson, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1874-1881

[9] Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults [J].

Staszewski, S ;

Morales-Ramirez, J ;

Tashima, KT ;

Rachlis, A ;

Skiest, D ;

Stanford, J ;

Stryker, R ;

Johnson, P ;

Labriola, DF ;

Farina, D ;

Manion, DJ ;

Ruiz, NM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1865-1873

[10]

STASZEWSKI S, 1999, 39 INT C ANT AG CHEM, P472